Australian & New Zealand Childrens Haematology/Oncology Group

Clinical Trials

Viewing: Clinical Trials

Filter by

Craniopharyngioma

Status: Preparing to Open

PNOC029: Nivolumab and DAY101 for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults

Adamantinomatous Craniopharyngioma

Status: In Development

CONNECT2108: Phase 2 Study of the MEK inhibitor MEKTOVI® (binimetinib) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

Medulloblastoma

Status: In Development

SJiMB21: Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children with Newly Diagnosed Medulloblastoma

Acute Lymphoblastic Leukemia

Status: Preparing to Open

RAVEN: A phase I/II trial treating relapsed acute lymphoblastic leukemia with venetoclax and navitoclax

Adamantinomatous Craniopharyngioma

Status: Open | WA

CONNECT1905: Phase 2 Study of Systemic IL-6 Receptor Antagonist ACTEMRA® (tocilizumab) for the treatment of Progressive/Recurrent Pediatric Adamantinomatous Craniopharyngioma

Medulloblastoma

Status: Open | NSW , VIC

MetMED: Phase III randomized double-blind placebo-controlled trial of metformin for white matter repair and cognitive recovery in paediatric brain tumour patients

All posts loaded.

All posts loaded.

Load more trials